Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.52 |
| ▸ | DAO | P14920 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 6/20 | 0.48 |
| ▸ | CASP3 | P42574 | 2/20 | 0.45 |
| ▸ | CASP7 | P55210 | 2/20 | 0.45 |
| ▸ | CASP2 | P42575 | 1/20 | 0.45 |
| ▸ | CASP6 | P55212 | 1/20 | 0.45 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | RGS12 | O14924 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29485716 | 1.00 | GSK3B (0.52) | GSK3BDAOKDM4EALDH1A1GAA | |
| SCHEMBL29025704 | 0.98 | GSK3B (0.50) | GSK3BDAOKDM4EALDH1A1GAA | |
| SCHEMBL30364460 | 0.98 | GSK3B (0.50) | GSK3BDAOKDM4EALDH1A1GAA | |
| Hydrochloric Acid SCHEMBL7736928 | 0.98 | GSK3B (0.50) | GSK3BDAOKDM4EALDH1A1GAA | |
| Hydrochloric Acid SCHEMBL29864773 | 0.98 | GSK3B (0.50) | GSK3BDAOKDM4EALDH1A1GAA | |
| Phthalimide SCHEMBL8855990 | 0.96 | GSK3B (0.60) | GSK3BDAOKDM4EALDH1A1GAA | |
| Dimethylamine SCHEMBL3813435 | 0.94 | KDM4E (0.51) | GSK3BDAOKDM4EALDH1A1GAA | |
| SCHEMBL28989737 | 0.89 | KDM4E (0.44) | GSK3BDAOKDM4EALDH1A1GAA | |
| SCHEMBL22525286 | 0.88 | DAO (0.58) | GSK3BDAOKDM4EALDH1A1GAA | |
| SCHEMBL22904118 | 0.86 | GSK3B (0.52) | GSK3BDAOKDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 628 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4206205-B1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE BEIJING CO LTD (CN) | 2026-03-04 | — | — | EP | claimed |
| CN-115991685-B | Preparation method of oxetane-2-methylamine | 韶远科技（上海)有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119504556-A | Bisphenol phthaloyl Process for producing imine | 潍坊弘润石化科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-118084674-A | Method for preparing deuterated methylamine hydrochloride by using methyl triflate-D3 | 西安瑞联新材料股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117342998-A | Diamine monomer containing N-aminophthalimide structure, preparation method thereof, polyimide compound and application | 浙江工业大学 | 2024-01-05 | — | — | CN | claimed |
| US-20230303578-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE (BEIJING) CO., LTD. (CN) | 2023-09-28 | — | — | US | claimed |
| EP-4206205-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | Primegene (Beijing) Co., Ltd. (CN) | 2023-07-05 | — | — | EP | claimed |
| US-20230151236-A1 | MAGENTA PIGMENT DISPERSANTS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2023-05-18 | — | — | US | claimed |
| CN-115991685-A | Preparation method of oxetane-2-methylamine | 韶远科技（上海)有限公司 | 2023-04-21 | — | — | CN | claimed |
| EP-4143157-A1 | METHODS OF MANUFACTURE OF DIANHYDRIDES | Chaulagain, Mani (US) | 2023-03-08 | — | — | EP | claimed |
| CN-101021511-A | Method for detecting purity of 3,5 substituted oxazolidones compound | SICHUAN BEILIKE BIOTECHNIC CO (CN) | 2007-08-22 | — | — | CN | claimed |
| CN-101021487-A | Method for assaying 3,5-substituted oxazolidones compound content | SICHUAN BEILIKE BIOTECHNIC CO (CN) | 2007-08-22 | — | — | CN | claimed |
| CN-101021512-A | Method for detecting content of 3,5-substituted oxaolidones compound | SICHUAN BEILIKE BIOTECHNICS CO (CN) | 2007-08-22 | — | — | CN | claimed |
| US-7053129-B1 | Process for preparing monodisperse anion exchangers | BAYER AKTIENGESELLSCHAFT (DE) | 2006-05-30 | — | — | US | claimed |
| US-6649663-B1 | Addition copolymerizing and crosslinking monovinylaromatic compound and polyvinylaromatic compound; amidomethylating with phthalimide or methylphthalimide | BAYER AKTIENGESELLSCHAFT (DE) | 2003-11-18 | — | — | US | claimed |
| US-6329435-B1 | REACTING MONOMER DROPLETS OF MONOVINYLAROMATIC COMPOUND AND POLYVINYLAROMATIC COMPOUND TO GIVE BEAD POLYMER; AMIDOMETHYLATING, CONVERTING TO AMINOMETHYLATED BEAD POLYMER, REACTING WITH THIOUREA OR ITS DERIVATIVE | BAYER AKTIENGESELLSCHAFT (DE) | 2001-12-11 | — | — | US | claimed |
| EP-0299421-B1 | Imide modified epoxy resins | DOW CHEMICAL CO (US) | 1996-03-13 | — | — | EP | claimed |
| US-4847348-A | BINDERS, COATINGS | THE DOW CHEMICAL COMPANY (US) | 1989-07-11 | — | — | US | claimed |
| EP-0299421-A2 | Imide modified epoxy resins | THE DOW CHEMICAL COMPANY (US) | 1989-01-18 | — | — | EP | claimed |
| US-4207112-A | STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1980-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303578-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | DPYD, RPLP2, DHPS | GSK3B 3303/4885DAO 2589/4885KDM4E 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.